Hospital Son Espases, Palma Mallorca Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial
2009
NCT02070133
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Alternative names

Hospital Son Espases de Mallorca

Active Ingredients

Drugs in Phase 3 Trials (1)

simvastatin (zocor) (1 trial)

Drugs in Other Trials (1)

oxygen (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Lung Diseases (Phase 3)

Lung Diseases, Obstructive (Phase 3)

Pulmonary Disease, Chronic Obstructive (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 2